A traditional CRO,
in an ever-evolving world
Reputation & Experience
Israel was among the world’s earliest adopters of a legal medical cannabis program and, as such, is recognized as the global leader in the study of the Cannabis Sativa plant. Either as a stand-alone or as part of a multi-center approach, we can implement clinical trials compliant with international standards including ICH GCP, The Clinical Trial Directive 2001/20/EU and the code of Federal Regulations (FDA 21 CFR).
EndoCRO is proud of its close ties to some of Israel’s most experienced growers, formulators and manufacturers, and can supply the investigational products in adherence to the study protocol, GMP and local regulations.
Culture of Integrity
We are leaders in both research and the clinical study of cannabis medicine. We are unparalleled in our global understanding and application of every part of the medical cannabis chain.
World Class Specialists
Working with leading Principal Investigators and their teams, EndoCRO has a professional network of physicians in four of the largest hospitals in Israel. These centers have all participated in multi-site, multinational, GCP studies. Additionally, we offer multi-center studies in Israel, Canada, Australia and the United States.
EndoCRO provides a complete range of contract development and contract clinical services including: